ASX - By Stock
|
SPL |
Re:
Ann: Positive AZD0466 clinical data presented by AstraZeneca
|
|
peony-rose
|
51 |
14K |
5 |
14/12/22 |
14/12/22 |
ASX - By Stock
|
51
|
14K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive AZD0466 clinical data presented by AstraZeneca
|
|
peony-rose
|
51 |
14K |
11 |
13/12/22 |
13/12/22 |
ASX - By Stock
|
51
|
14K
|
11
|
|
ASX - By Stock
|
SPL |
Re:
DEP-Gemcitabine
|
|
peony-rose
|
28 |
6.5K |
0 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
28
|
6.5K
|
0
|
|
ASX - By Stock
|
SPL Automobiles |
Re:
Quistions and Answers
|
|
peony-rose
|
7 |
5.4K |
2 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
7
|
5.4K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze debacle vs VivaGel debacle
|
|
peony-rose
|
13 |
3.6K |
1 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
13
|
3.6K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE launched in Hong Kong and Macau
|
|
peony-rose
|
111 |
26K |
3 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
111
|
26K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE launched in Hong Kong and Macau
|
|
peony-rose
|
111 |
26K |
4 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
111
|
26K
|
4
|
|
ASX - By Stock
|
SGM |
Re:
Ann: Trading Update
|
|
peony-rose
|
16 |
4.8K |
3 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
16
|
4.8K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Interim results DEP-Cabazitaxel
|
|
peony-rose
|
15 |
3.4K |
1 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
15
|
3.4K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
The control number is 131488
|
|
peony-rose
|
8 |
1.8K |
1 |
02/11/22 |
02/11/22 |
ASX - By Stock
|
8
|
1.8K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
The control number is 131488
|
|
peony-rose
|
8 |
1.8K |
2 |
02/11/22 |
02/11/22 |
ASX - By Stock
|
8
|
1.8K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Warning~potential investors
|
|
peony-rose
|
9 |
2.8K |
1 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
9
|
2.8K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Warning~potential investors
|
|
peony-rose
|
9 |
2.8K |
3 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
9
|
2.8K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
peony-rose
|
37 |
11K |
16 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
37
|
11K
|
16
|
|
ASX - By Stock
|
SGM |
Re:
Buying opportunity
|
|
peony-rose
|
11 |
4.8K |
0 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
11
|
4.8K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - J Fairley
|
|
peony-rose
|
8 |
2.7K |
0 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
8
|
2.7K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - J Fairley
|
|
peony-rose
|
8 |
2.7K |
2 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
8
|
2.7K
|
2
|
|
ASX - General
|
|
Re:
CommSec or the ASX not operating @ 10.04 am
|
|
peony-rose
|
43 |
13K |
1 |
04/10/22 |
04/10/22 |
ASX - General
|
43
|
13K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Old boys s
|
|
peony-rose
|
8 |
3.1K |
0 |
27/09/22 |
27/09/22 |
ASX - By Stock
|
8
|
3.1K
|
0
|
|
ASX - By Stock
|
SPL |
Old boys s
|
|
peony-rose
|
8 |
3.1K |
0 |
26/09/22 |
26/09/22 |
ASX - By Stock
|
8
|
3.1K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
ADR follows lead
|
|
peony-rose
|
16 |
4.7K |
1 |
22/09/22 |
22/09/22 |
ASX - By Stock
|
16
|
4.7K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Substantial holders continue to top up
|
|
peony-rose
|
47 |
14K |
3 |
19/09/22 |
19/09/22 |
ASX - By Stock
|
47
|
14K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Substantial holders continue to top up
|
|
peony-rose
|
47 |
14K |
2 |
19/09/22 |
19/09/22 |
ASX - By Stock
|
47
|
14K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Mirrabooka creeps up the list of top 20 holders in Starpharma
|
|
peony-rose
|
43 |
13K |
5 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
43
|
13K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Mirrabooka creeps up the list of top 20 holders in Starpharma
|
|
peony-rose
|
43 |
13K |
2 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
43
|
13K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma goes into overdrive - Fear and Greed
|
|
peony-rose
|
81 |
21K |
5 |
03/09/22 |
03/09/22 |
ASX - By Stock
|
81
|
21K
|
5
|
|
ASX - By Stock
|
FMG |
Re:
FMG Technical Analysis
|
|
peony-rose
|
11K |
10M |
4 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
11K
|
10M
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE relaunched by LloydsPharmacy in the UK
|
|
peony-rose
|
253 |
67K |
3 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
253
|
67K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze
|
|
peony-rose
|
95 |
30K |
0 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
95
|
30K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze
|
|
peony-rose
|
95 |
30K |
4 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
95
|
30K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Remember the Agro
|
|
peony-rose
|
13 |
3.0K |
1 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
13
|
3.0K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Quietly confident despite sp games
|
|
peony-rose
|
29 |
8.1K |
1 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
29
|
8.1K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Quietly confident despite sp games
|
|
peony-rose
|
29 |
8.1K |
1 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
29
|
8.1K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Quietly confident despite sp games
|
|
peony-rose
|
29 |
8.1K |
2 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
29
|
8.1K
|
2
|
|
ASX - By Stock
|
HCW |
Re:
target price $1.50
|
|
peony-rose
|
25 |
13K |
0 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
25
|
13K
|
0
|
|
ASX - By Stock
|
HCW |
Re:
target price $1.50
|
|
peony-rose
|
25 |
13K |
1 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
25
|
13K
|
1
|
|
ASX - By Stock
|
SGL |
Re:
Ann: Investor Presentation
|
|
peony-rose
|
5 |
3.4K |
1 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
5
|
3.4K
|
1
|
|
ASX - By Stock
|
SGM |
Re:
Buying opportunity
|
|
peony-rose
|
11 |
4.8K |
5 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
11
|
4.8K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities Report & Appendix 4C
|
|
peony-rose
|
77 |
20K |
1 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
77
|
20K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Watch out disparaging and defamatory posters
|
|
peony-rose
|
11 |
3.2K |
2 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
11
|
3.2K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Monkey Pox Virus
|
|
peony-rose
|
11 |
2.6K |
0 |
24/07/22 |
24/07/22 |
ASX - By Stock
|
11
|
2.6K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
something has to give.....the share price is absolutely ridiculous
|
|
peony-rose
|
47 |
11K |
0 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
47
|
11K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Management team
|
|
peony-rose
|
9 |
2.7K |
1 |
18/07/22 |
18/07/22 |
ASX - By Stock
|
9
|
2.7K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
SPL chart
|
|
peony-rose
|
451 |
141K |
2 |
14/07/22 |
14/07/22 |
ASX - By Stock
|
451
|
141K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE relaunched by LloydsPharmacy in the UK
|
|
peony-rose
|
253 |
67K |
7 |
12/07/22 |
12/07/22 |
ASX - By Stock
|
253
|
67K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
SPL chart
|
|
peony-rose
|
451 |
141K |
3 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
451
|
141K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
SPL chart
|
|
peony-rose
|
451 |
141K |
1 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
451
|
141K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Why hasn't the TGA approved Viraleze in Australia yet!!!
|
|
peony-rose
|
49 |
12K |
0 |
28/06/22 |
28/06/22 |
ASX - By Stock
|
49
|
12K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL signs expanded DEP research agreement with US Biopharma
|
|
peony-rose
|
29 |
8.5K |
1 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
29
|
8.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Chairman Rob Thomas
|
|
peony-rose
|
27 |
9.2K |
5 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
27
|
9.2K
|
5
|
|